policy, regulation, public health

After the release of an undercover investigation, Corteva Agrisciences announces it will release 36 beagles for rehoming.

Scientists say that increasingly rigorous licensing procedures have complicated research efforts—and in some cases, stopped experiments completely.

Conceived as a way to resolve differences between government regulators and academics over the chemical’s effects, the CLARITY-BPA collaboration instead highlights divisions.

Joey Ramp went back to college to study post-traumatic stress disorder. But the dogs that help her manage her own PTSD complicate her research career.

Opponents of the guidelines, which would bar results of many public health studies from use in policy making, include scientific and healthcare organizations.

Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.

President Trump’s pick, Judge Brett Kavanaugh, has often opposed court involvement in environmental and health regulations.

As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.

Vanessa Allen Sutherland will resign next month, leaving the agency with just three members of what should be a five-person board.

The findings of an official report come a month after a German court ruled in favor of banning diesel cars.

Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.

A US Court of Appeals ruled that the Interior Department acted prematurely in removing the animals from the endangered species list.

The Association for Molecular Pathology finds fault in the agency’s report on safety issues associated with certain lab tests.

US Food and Drug Administration commissioner Margaret Hamburg is stepping down after six years on the job.

A new agreement in the European Union allows genetically engineered crops to be approved without member-state votes, likely allowing several GMO foods to enter the market.

The US government releases its policy on so-called dual-use research involving dangerous pathogens that could be used for biological terrorist attacks.

Most stem cell lines registered with the NIH don’t comply with the FDA’s guidelines for human use, according to a new report.